3rd Quarter - Report — BOEHRINGER INGELHEIM USA CORPORATION, F… for BOEHRINGER INGELHEIM USA CORPORATION (2018)

Firm

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

Client

BOEHRINGER INGELHEIM USA CORPORATION

Income

—

Expenses

$450,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Average Sales Price; Reimbursement; CMS Rule coding for Biosimilars; Biosimilars and the Part D Coverage Gap Discount; Biosimilars Pass-Through Status in Part B

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—
LEAH D SVOBODA	—
MARY BRIDGET WALSH	—

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); SENATE

Animal Health - The Animal Drug and Animal Generic Drug User Fee Amendments of 2018 Farm Bill - U.S. Foot and Mouth Disease Vaccine Bank Senate = Agriculture Improvement Act of 2018 (S.3042) House = Agriculture and Nutrition Act of 2018 (H.R. 2)

Lobbyist	Covered position, as disclosed
BILL DAVIS	—
LEAH D SVOBODA	—
MARY BRIDGET WALSH	—

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2 (115th), S. 3042 (115th)

Accounting ACC

Importation - Affordable and Safe Prescription Drug Importation Act (S469)

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—
LEAH D SVOBODA	—
MARY BRIDGET WALSH	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Health Issues HCR

Cost Sharing (Preserving Access to Medicines); S. Amendment 178; to S. Con. Res. 3 and HR/245 & S.469 House & Senate bills titled the Affordable Safe and Prescription Drug Importation Act. Diabetes and Heart Health Awareness and Chronic Pulmonary Disease Awareness

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—
LEAH D SVOBODA	—

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 469 (115th), S.Con.Res. 3 (115th)

Budget/Appropriations BUD

House & Senate Budget Bills; Rebates for Dual Eligible, Low Income Subsidy Populations and Drug Pricing in the following: S. Con. Res. 3 - 2017 Budget President's 2018 Budget Blue Print; President's American Patients First Blueprint Bipartisan Budget Act of 2018

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—
LEAH D SVOBODA	—
MARY BRIDGET WALSH	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: S.Con.Res. 3 (115th)

Consumer Issues/Safety/Products CSP

Anti-Counterfeiting; S.469 - The Affordable and Safe Drug Importation Act

Lobbyist	Covered position, as disclosed
JONATHAN REA MCPHERSON	—
LEAH D SVOBODA	—
MARY BRIDGET WALSH	—

Contacted: Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 469 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.

BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION